Safety Study of Olpatadine Nasal Spray.

Trial Profile

Safety Study of Olpatadine Nasal Spray.

Phase of Trial: Phase III

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Olopatadine (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 05 Feb 2010 Status changed from active, no longer recruiting to completed as reported by
    • 18 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top